Skip to content

Clinical trials

Immunoblastic Lymphadenopathy trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Status: Unknown status Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20062
20072
20082
20091
20101
20122
20151
20161
20171
20181
20191
20202
20211
20222
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ruijin Hospital3
Cancer Research UK2
Jonsson Comprehensive Cancer Center2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2
Clatterbridge Centre for Oncology1
Herbert Irving Comprehensive Cancer Center1
Huijing Wu1
Institut Català d'Oncologia1
Institut Paoli-Calmettes1
Ou Bai, MD/PHD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy27
Lymphoma, Large-Cell, Anaplastic15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma12
Lymphoma11
Hodgkin Disease10
Lymphoma, Large B-Cell, Diffuse10
Lymphoma, Non-Hodgkin9
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma, B-Cell, Marginal Zone8
Lymphoma, Extranodal NK-T-Cell8

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.